| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Nature's Sunshine Products, Inc
13D/A
NATR · 639027101
|
0.4% |
6/27/2025
Event 6/25/2025
|
||||
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.4% | |||||
| Fosun Pharma USA Inc. | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.